Filing Flows

Filing Flows › Organogenesis Holdings (ORGO) › Next earnings date

Organogenesis Holdings (ORGO) earnings: missed the estimate

Organogenesis Holdings (ORGO) reported on Nov 5, 2026 and missed the EPS estimate: −$0.23 against −$0.17 (-33.6%). Revenue was $45.5M for Q3 2026, -70% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−33.6% vs estimate
Beat rate40%

The last report

Organogenesis Holdings reported revenue of $45.5M for the third quarter 2026 (-70% Y/Y), net loss $29.6M. How it makes money → · Every quarter →

Organogenesis Holdings: EPS against the estimate, last 5 reportsOrganogenesis Holdings: EPS against the estimate, last 5 reportsEstimateReported$0.07$0.18Nov 25$0.21$0.40Feb 26−$0.29−$0.34May 26−$0.35−$0.69Aug 26−$0.17−$0.23Nov 26
Latest (Nov 26): Estimate −$0.17, Reported −$0.23.

Organogenesis Holdings' latest quarter

Organogenesis Holdings, Q3 2026: revenue $45.5M (-70% year over year), operating margin -64.9%, net loss $29.6M, operating cash flow −$18.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did Organogenesis Holdings beat earnings?

Organogenesis Holdings (ORGO) reported on Nov 5, 2026 and missed the EPS estimate: −$0.23 against −$0.17 (-33.6%).

When does ORGO report earnings?

The next date is not set yet.

Does Organogenesis Holdings usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.